Open original FDA record ↗Recall record
- FDA identifier
- Z-1604-2015
- Company in FDA record
- HeartWare Inc
- FDA classification date
- May 14, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Failures of the splice repair kit if exposed to excessive force.
Source facts
- Action
- HeartWare, Inc. sent an Urgent Medical Device Correction letter to all affected consignees on May 11, 2015. The letter identified the affected product, problem, and actions to be taken by the consignees. The firm requested that consignees: 1) review the notice and the Patient Communication contents, 2) forward the notice to individuals within their organization who need to be aware of the notice, 3) identify patients that are currently on support and have undergone a driveline splice repair, 4) distribute the Patient Communication to the affected patients in person, 5) continue to reinforce the messages described in the notice with patients who have experienced a splice repair during their regularly scheduled appointments, 6) complete, sign, and return the "Acknowledge and Completion Form to HeartWare within 30 days of receipt of the letter. Should any questions or concerns arise, please contact there local HeartWare representative. Their 24-hour Clinical Support personnel are also available at 1 (888) 494-6365.
- Initiated
- 2015-04-29
- Root cause
- Device Design
- Distribution
- Worldwide Distribution - US Nationwide in the states of FL, KY, MO, NY, TN,TX, and the countries of: Canada, Germany, Italy, Netherlands, Turkey and United Kingdom.
- Recall number
- Z-1604-2015
- Recall status
- Open, Classified
- CDRH record ID
- 136083
- FDA classified
- 2015-05-14
- Recall event number
- 71099